http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106636444-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106636444-B |
titleOfInvention | Use of FAM78A gene |
abstract | The invention discloses an application of FAM78A gene in preparing a product for diagnosing lung adenocarcinoma and/or a pharmaceutical composition for treating lung adenocarcinoma. The invention discloses a method for screening a potential substance for treating lung adenocarcinoma, which indicates that the substance is a potential substance for treating lung adenocarcinoma when a candidate substance added into a system expressing or containing a FAM78A gene or a protein coded by the FAM78A gene can increase the expression and/or activity of FAM 78A. The FAM78A gene related to the occurrence and development of lung adenocarcinoma disclosed by the invention can be used as a biomarker of lung adenocarcinoma, and helps doctors to formulate personalized treatment schemes. |
priorityDate | 2017-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 405.